Predictors of fitness to drive in people with Parkinson disease.
نویسندگان
چکیده
OBJECTIVE To develop an efficient clinical screening battery to accurately predict the fitness to drive in people with Parkinson disease (PD). METHODS This prospective study included 80 participants: 40 patients with PD and 40 healthy age- and sex-matched control subjects. All participants were assessed using a driving simulator, a driving history survey, and the Clinical Dementia Rating. The patients with PD also underwent a clinical test battery and an evaluation of fitness to drive performed by an official center, which included visual, cognitive, and on-road tests. A two-class decision from this driving assessment center was the main outcome measure. RESULTS A screening battery assessing four clinical variables (disease duration, contrast sensitivity, Clinical Dementia Rating, and motor part of the Unified Parkinson's Disease Rating Scale) provided the best model (R(2) = 0.52) to predict the fitness to drive and correctly classified 36 (90%) of the patients with PD as pass or fail (sensitivity = 91%, specificity = 90%). The Test Ride for Investigating Practical fitness to drive (TRIP) driving simulator score discriminated significantly between drivers with PD and their healthy peers (p = 0.0008). When the TRIP driving simulator score was added to the clinical model, the total explained variance increased (R(2) = 0.60) and correctly classified 39 (97.5%) of drivers with PD into the pass/fail category (sensitivity = 91%, specificity = 100%). CONCLUSIONS A short clinical screening battery that measures disease duration, contrast sensitivity, cognitive and motor functions can predict fitness to drive in people with Parkinson disease with a high degree of accuracy.
منابع مشابه
رابطه علی ادراک بیماری، پیروی دارویی وکیفیت زندگی در سالمندان مبتلا به پارکینسون
Parkinson Disease (PD) is a type of degenerative disorder for central nervous system at old age. The present study is intended to review the effectiveness of Cognitive- Behavioral Therapy (CBT) on quality of life among the old people who suffer from Parkinson disease. In this survey, the methodology was considered as semi- experimental with pre- test and post- test plan along with a control gro...
متن کاملP181: Effect of Aquatic Therapy on Improvement of Patients with Parkinson Disease: A Systematic Review
Parkinson disease (PD) is a degenerative neurological disorder that affects 0.5- 1% of old people in western countries. It primarily affects mobility function, and associated with increasing disability over time. People with PD express bradykinesia, rigidity, tremor, progressive postural instability and muscle weakness as symptoms of PD. Various exercise programs, including resistance or aerobi...
متن کاملIron serum level and TIBC in porkinson disease
Parkinson disease is one of the neurodegenetive disease with a prevalence of about 1% in people older than 65.from a pathological point of view,degeneration of neuromelanin cells in pars compacta of substantia nigra has been established.the reason of degeneration is unknouwn.increase in iron concentration in substantia of parkinson,s patients has been established.the increase of iron in this p...
متن کاملP 105: The Role of LRRK2 Inhibitors in Treatment of Parkinson’s Disease
Parkinson’s disease is the second most common age associated neuron degenerative disorder in developed societies. With the prevalence ranging from 41 per 100000 in the fourth decade of life to over 1900 per 100000 in people over 80 years of age.it characterized clinically by resting tremor, slowness of movement, rigidity and postural instability in the result of progressive loss of dopami...
متن کاملP 48: Pioglitazone in Early Parkinson: A Review Study
More than 10 million people worldwide are living with Parkinson’s disease (PD). The ages of people who have Parkinson are variable, usually between 50 and 80 years, the average of them is 55 years old. The symptoms of PD are progressive, and within 10 to 20. It happens when dopaminergic neurons were being degenerate. Peripheral and central inflammatory and oxidative stress pathways play a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Neurology
دوره 69 14 شماره
صفحات -
تاریخ انتشار 2007